Abstract

In yeast, many tandemly arranged genes show peak expression in different phases of the metabolic cycle (YMC) or in different carbon sources, indicative of regulation by a bi-modal switch, but it is not clear how these switches are controlled. Using native elongating transcript analysis (NET-seq), we show that transcription itself is a component of bi-modal switches, facilitating reciprocal expression in gene clusters. HMS2, encoding a growth-regulated transcription factor, switches between sense- or antisense-dominant states that also coordinate up- and down-regulation of transcription at neighbouring genes. Engineering HMS2 reveals alternative mono-, di- or tri-cistronic and antisense transcription units (TUs), using different promoter and terminator combinations, that underlie state-switching. Promoters or terminators are excluded from functional TUs by read-through transcriptional interference, while antisense TUs insulate downstream genes from interference. We propose that the balance of transcriptional insulation and interference at gene clusters facilitates gene expression switches during intracellular and extracellular environmental change.

Article and author information

Author details

  1. Tania Nguyen

    University of Oxford, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
  2. Harry Fischl

    University of Oxford, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
  3. Françoise S Howe

    University of Oxford, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
  4. Ronja Woloszczuk

    University of Oxford, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
  5. Ana Serra Barros

    University of Oxford, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
  6. Zhenyu Xu

    European Molecular Biology Laboratory, Heidelberg, Germany
    Competing interests
    No competing interests declared.
  7. David Brown

    University of Oxford, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
  8. Struan C Murray

    University of Oxford, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
  9. Simon Haenni

    University of Oxford, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
  10. James M Halstead

    University of Oxford, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
  11. Leigh O'Connor

    University of Oxford, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
  12. Gergana Shipkovenska

    University of Oxford, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
  13. Lars M Steinmeetz

    European Molecular Biology Laboratory, Heidelberg, Germany
    Competing interests
    No competing interests declared.
  14. Jane Mellor

    University of Oxford, Oxford, United Kingdom
    For correspondence
    jane.mellor@bioch.ox.ac.uk
    Competing interests
    Jane Mellor, I am an advisor to Oxford Biodynamics Ltd and Sibelius Ltd and sit on the board of Chronos Therapeutics. OBD provided funding for this work but like all the funders, had no say in the design or outcome of the research and do not benefit in any way from this research.

Copyright

© 2014, Nguyen et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Download links

Share this article

https://doi.org/10.7554/eLife.03635

Further reading

    1. Computational and Systems Biology
    2. Genetics and Genomics
    Fangluo Chen, Dylan C Sarver ... G William Wong
    Research Article

    Obesity is a major risk factor for type 2 diabetes, dyslipidemia, cardiovascular disease, and hypertension. Intriguingly, there is a subset of metabolically healthy obese (MHO) individuals who are seemingly able to maintain a healthy metabolic profile free of metabolic syndrome. The molecular underpinnings of MHO, however, are not well understood. Here, we report that CTRP10/C1QL2-deficient mice represent a unique female model of MHO. CTRP10 modulates weight gain in a striking and sexually dimorphic manner. Female, but not male, mice lacking CTRP10 develop obesity with age on a low-fat diet while maintaining an otherwise healthy metabolic profile. When fed an obesogenic diet, female Ctrp10 knockout (KO) mice show rapid weight gain. Despite pronounced obesity, Ctrp10 KO female mice do not develop steatosis, dyslipidemia, glucose intolerance, insulin resistance, oxidative stress, or low-grade inflammation. Obesity is largely uncoupled from metabolic dysregulation in female KO mice. Multi-tissue transcriptomic analyses highlighted gene expression changes and pathways associated with insulin-sensitive obesity. Transcriptional correlation of the differentially expressed gene (DEG) orthologs in humans also shows sex differences in gene connectivity within and across metabolic tissues, underscoring the conserved sex-dependent function of CTRP10. Collectively, our findings suggest that CTRP10 negatively regulates body weight in females, and that loss of CTRP10 results in benign obesity with largely preserved insulin sensitivity and metabolic health. This female MHO mouse model is valuable for understanding sex-biased mechanisms that uncouple obesity from metabolic dysfunction.

    1. Computational and Systems Biology
    Huiyong Cheng, Dawson Miller ... Qiuying Chen
    Research Article

    Mass spectrometry imaging (MSI) is a powerful technology used to define the spatial distribution and relative abundance of metabolites across tissue cryosections. While software packages exist for pixel-by-pixel individual metabolite and limited target pairs of ratio imaging, the research community lacks an easy computing and application tool that images any metabolite abundance ratio pairs. Importantly, recognition of correlated metabolite pairs may contribute to the discovery of unanticipated molecules in shared metabolic pathways. Here, we describe the development and implementation of an untargeted R package workflow for pixel-by-pixel ratio imaging of all metabolites detected in an MSI experiment. Considering untargeted MSI studies of murine brain and embryogenesis, we demonstrate that ratio imaging minimizes systematic data variation introduced by sample handling, markedly enhances spatial image contrast, and reveals previously unrecognized metabotype-distinct tissue regions. Furthermore, ratio imaging facilitates identification of novel regional biomarkers and provides anatomical information regarding spatial distribution of metabolite-linked biochemical pathways. The algorithm described herein is applicable to any MSI dataset containing spatial information for metabolites, peptides or proteins, offering a potent hypothesis generation tool to enhance knowledge obtained from current spatial metabolite profiling technologies.